{"id":"anyu-peibo","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Insomnia"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by modulating the activity of certain neurotransmitters in the brain, such as serotonin and dopamine, to improve mood and reduce symptoms of depression.","oneSentence":"Anyu Peibo is a medication used to treat depression.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:42:46.967Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"}]},"trialDetails":[{"nctId":"NCT04210973","phase":"PHASE3","title":"Comparison of Anyu Peibo With Placebo in Treatment of MDD in China","status":"UNKNOWN","sponsor":"Shanghai Mental Health Center","startDate":"2020-01-23","conditions":"Major Depressive Disorder","enrollment":266},{"nctId":"NCT02380066","phase":"PHASE2","title":"Comparison of Anyu Peibo With Placebo in Treatment of MDD","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2015-03","conditions":"Major Depressive Disorder (MDD)","enrollment":120},{"nctId":"NCT03183505","phase":"PHASE2","title":"Comparison of Anyu Peibo With Placebo in Treatment of MDD，Ⅱb","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2017-06-30","conditions":"Major Depressive Disorder","enrollment":172}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo","Anyu Peibo Capsule"],"phase":"phase_3","status":"active","brandName":"Anyu Peibo","genericName":"Anyu Peibo","companyName":"Shanghai Mental Health Center","companyId":"shanghai-mental-health-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Anyu Peibo is being studied as a potential treatment for Major Depressive Disorder (MDD) in a clinical trial. The trial, titled \"Safety and Efficacy Study of Anyu Peibo in Treatment of MDD\", is comparing the efficacy of Anyu Peibo to a placebo in patients with MDD.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}